NTLA Market Cap History
Below is a table of the NTLA market cap history going back to 5/6/2016:

Date NTLA Market Cap

Also see: NTLA Shares Outstanding History
and NTLA YTD Return
NTLA Historical Market Cap:
+59.59% CAGR
NTLA Historical Market Cap: +59.59% CAGR

Mouse over chart for data details
5/6/2016 ...10/29/2021
Intellia Therapeutics is a genome editing company focused on developing therapeutics utilizing a biological tool known as Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated 9 (Cas9). This is a technology for genome editing, the process of altering selected sequences of genomic deoxyribonucleic acid. Co. utilizes its CRISPR/Cas9 platform across two areas: in vivo and ex vivo therapies. Co.'s in vivo candidate, NTLA-2001 for the treatment of transthyretin amyloidosis is the delivered CRISPR/Cas9-based therapy to enter clinical evaluation. Co.'s ex vivo applications to address immuno-oncology and autoimmune diseases. We show 24 historical shares outstanding datapoints in our NTLA shares outstanding history coverage, used to compute NTLA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing NTLA market cap history over the course of time is important for investors interested in comparing NTLA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of NTLA versus a peer is one thing; comparing NTLA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like NTLA can fluctuate over the course of history. With this page we aim to empower investors researching NTLA by allowing them to research the NTLA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree NTLA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Intellia Therapeutics (NTLA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

NTRA Market Cap History
NTRB Market Cap History
NTRP Market Cap History
NTUS Market Cap History
NURO Market Cap History
NUVA Market Cap History
NUVL Market Cap History
NUWE Market Cap History
NVAX Market Cap History
NVIV Market Cap History
More Healthcare companies »


NTLA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.